| 2025-11-04 |
财报披露：
美东时间 2025-11-04 盘后发布财报
|
| 2025-11-03 |
详情>>
股本变动：
变动后总股本11455.42万股
变动原因 ▼▲
- 原因：
- From June 30, 2025 to September 30, 2025
Issuance of common stock upon vesting of RSUs and settlement of PSUs, net of shares used for tax withholdings
Purchase of shares under Stock Repurchase Program
|
| 2025-11-03 |
详情>>
业绩披露：
2025年三季报(累计)每股收益4.70美元,归母净利润5.39亿美元,同比去年增长-7.39%
|
| 2025-08-01 |
详情>>
业绩披露：
2025年中报每股收益3.35美元,归母净利润3.84亿美元,同比去年增长12.43%
|
| 2025-05-02 |
详情>>
业绩披露：
2025年一季报每股收益1.59美元,归母净利润1.82亿美元,同比去年增长38.93%
|
| 2025-04-07 |
股东大会：
将于2025-05-22召开股东大会
会议内容 ▼▲
- 1.Elect nine individuals to our Board of Directors to serve until the next annual meeting of our stockholders and until their respective successors are elected and qualified, or until their earlier resignation or removal;
2.Hold an advisory vote to approve the compensation of our named executive officers;
3.Ratify the appointment by our Audit Committee of Ernst & Young LLP as our independent registered public accounting firm for 2025;
4.Consider and approve the Company’s 2025 Equity Incentive Compensation Plan;
5.Transact such other business that may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2025-02-20 |
详情>>
业绩披露：
2022年年报每股收益9.09美元,归母净利润11.12亿美元,同比去年增长2969.23%
|
| 2025-02-20 |
详情>>
业绩披露：
2024年年报每股收益6.71美元,归母净利润7.70亿美元,同比去年增长-5.82%
|
| 2024-11-01 |
详情>>
业绩披露：
2024年三季报(累计)每股收益5.07美元,归母净利润5.82亿美元,同比去年增长1.97%
|
| 2024-08-08 |
详情>>
业绩披露：
2024年中报每股收益2.97美元,归母净利润3.41亿美元,同比去年增长-1.99%
|
| 2024-08-08 |
详情>>
业绩披露：
2023年中报每股收益2.89美元,归母净利润3.48亿美元,同比去年增长-6.4%
|
| 2024-05-03 |
详情>>
业绩披露：
2024年一季报每股收益1.13美元,归母净利润1.31亿美元,同比去年增长-33.92%
|
| 2024-04-04 |
股东大会：
将于2024-05-23召开股东大会
会议内容 ▼▲
- 1.Elect nine individuals to our Board of Directors to serve until the next annual meeting of our stockholders and until their respective successors are elected and qualified, or until their earlier resignation or removal;
2.Hold an advisory vote to approve the compensation of our named executive officers;
3.Ratify the appointment by our Audit Committee of Ernst & Young LLP as our independent registered public accounting firm for 2024;
4.Transact such other business that may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2024-02-22 |
详情>>
业绩披露：
2023年年报每股收益6.89美元,归母净利润8.18亿美元,同比去年增长-26.45%
|
| 2023-11-03 |
详情>>
业绩披露：
2023年三季报(累计)每股收益4.77美元,归母净利润5.71亿美元,同比去年增长-33.13%
|
| 2023-04-13 |
股东大会：
将于2023-05-25召开股东大会
会议内容 ▼▲
- 1.Elect eight individuals to our Board of Directors to serve until the next annual meeting of our stockholders and until their respective successors are elected and qualified, or until their earlier resignation or removal;
2.Hold an advisory vote to approve the compensation of our named executive officers;
3.Hold an advisory vote on the frequency of advisory votes regarding the compensation of our named executive officers;
4.Ratify the appointment by our Audit Committee of Ernst & Young LLP as our independent registered public accounting firm for 2023;
5.Approve an amendment to our Restated Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation;
6.Transact such other business that may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2022-04-14 |
股东大会：
将于2022-05-26召开股东大会
会议内容 ▼▲
- 1.elect eight individuals to our Board of Directors to serve until the next annual meeting of our stockholders and until their respective successors are elected and qualified, or until their earlier resignation or removal;
2.hold an advisory vote to approve the compensation of our named executive officers;
3.ratify the appointment by our Audit Committee of Ernst & Young LLP as our independent registered public accounting firm for 2022;
4.transact such other business that may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-16 |
股东大会：
将于2021-05-27召开股东大会
会议内容 ▼▲
- 1.elect seven individuals to our Board of Directors to serve until the next annual meeting of our stockholders and until their respective successors are elected and qualified, or until their earlier resignation or removal;
2.hold an advisory vote to approve the compensation of our named executive officers;
3.ratify the appointment by our Audit Committee of Ernst & Young LLP as our independent registered public accounting firm for 2021;
4.consider and approve the Company’s 2021 Employee Stock Purchase Plan;
5.transact such other business that may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2020-04-17 |
股东大会：
将于2020-05-27召开股东大会
会议内容 ▼▲
- 1.elect nine individuals to our Board of Directors to serve until the next annual meeting of our stockholders and until their respective successors are elected and qualified, or until their earlier resignation or removal;
2.hold an advisory vote to approve the compensation of our named executive officers;
3.ratify the appointment by our Audit Committee of Ernst & Young LLP as our independent registered public accounting firm for 2020;
4.consider and approve an amendment to our Restated Certificate of Incorporation to authorize a reverse stock split of our outstanding shares of common stock, at a reverse stock split ratio ranging between 1-for-5 and 1-for-20, and a proportionate reduction in the number of authorized shares of our common stock, with an exact ratio as may be determined by our Board in its sole discretion at a later date (the “Reverse Stock Split”);
5.transact such other business that may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2019-04-15 |
股东大会：
将于2019-05-29召开股东大会
会议内容 ▼▲
- 1.elect nine individuals to our Board of Directors, to serve until the next annual meeting of our stockholders;
2.hold an advisory vote to approve the compensation of our named executive officers;
3.ratify the appointment by our Audit Committee of Ernst & Young LLP, as our independent registered public accounting firm for 2019;
4.transact such other business that may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2018-04-12 |
股东大会：
将于2018-05-22召开股东大会
会议内容 ▼▲
- 1.elect eight individuals to our Board of Directors, to serve until the next annual meeting of our stockholders;
2.ratify the appointment by our Audit Committee of Ernst & Young LLP, as our independent registered public accounting firm for 2018;
3.hold an advisory vote to approve the compensation of our named executive officers;
4.approve an amendment and restatement of our Equity Incentive Compensation Plan, including an increase in the stated total number of shares authorized for issuance under this plan from 14,100,000 shares to 17,500,000 shares;
5.transact such other business that may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2017-04-13 |
股东大会：
将于2017-05-23召开股东大会
会议内容 ▼▲
- 1.elect eight individuals to our Board of Directors, to serve until the next annual meeting of our stockholders;
2.ratify the appointment by our Audit Committee of Ernst & Young LLP, as our independent registered public accounting firm for 2017;
3.hold an advisory vote to approve the compensation of our named executive officers;
4.hold an advisory vote on the frequency of advisory votes regarding the compensation of our named executive officers;
5.approve an amendment to our Employee Stock Purchase Plan;
6.transact such other business that may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2016-04-13 |
股东大会：
将于2016-05-24召开股东大会
会议内容 ▼▲
- 1.elect eight individuals to our Board of Directors, to serve until the next annual meeting of our stockholders;
2.ratify the appointment by our Audit Committee of Ernst & Young LLP, as our independent registered public accounting firm for 2016;
3.hold an advisory vote to approve the compensation of our named executive officers;
4.approve an amendment and restatement of our Equity Incentive Compensation Plan, including an increase in the stated total number of shares authorized for issuance under this plan from 10,700,000 shares to 14,100,000 shares;
5.transact such other business that may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|